Meloxicam inhibited oxidative stress and inflammatory response of LPS-stimulated bovine endometrial epithelial cells through Nrf2 and NF-κB pathways
International Immunopharmacology · 2023-03 · 116 · 109822
DOI: 10.1016/j.intimp.2023.109822 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-03. Verfasst von Luying Cui und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Yangzhou University, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Disease a…. Hauptthemen laut MEDLINE: NF-kappa B, Lipopolysaccharides. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Meloxicam is a selective cyclooxygenase-2 inhibitor and has been widely used in combination with antibiotics to alleviate uterine inflammation and provide analgesia in postpartum cows. Studies have shown that meloxicam has antioxidant and anti-inflammatory effects. However, the link between meloxicam and uterine inflammation and oxidative stress in dairy cows has not been studied. The purpose of this study was to research the effects of meloxicam (0.5 or 5 μM) on oxidative stress and inflammatory response of primary bovine endometrial epithelial cells (BEEC) stimulated by Escherichia coli lipopolysaccharide (1 μg/mL LPS). As a result, LPS stimulated the production of oxidative stress markers and the expression of inflammatory factors, accompanied by a decrease in the activity and the gene transcription of antioxidant enzymes. Co-treatment of meloxicam and LPS reduced the content of oxidative stress markers and the mRNA levels of the pro-inflammatory genes, and improved antioxidant enzyme activities and the corresponding gene expression as compared with the cells treated with LPS alone. Meloxicam attenuated the inhibitory effect of the Nrf2 pathway and the phosphorylation levels of p65 and IκBα caused by LPS. In conclusion, meloxicam alone had no effect on BEEC, but prevented oxidative stress and inflammatory response in LPS-stimulated BEEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Yangzhou University, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Yangzhou, Jiangsu 220559, PR China; Joint International R…
Zitieren
APA
Cui, L., Guo, J., Wang, Z., Zhang, J., Li, W., Dong, J., Liu, K., Guo, L., Li, J., Wang, H., & Li, J. (2023). Meloxicam inhibited oxidative stress and inflammatory response of LPS-stimulated bovine endometrial epithelial cells through Nrf2 and NF-κB pathways. International Immunopharmacology, 116, 109822. https://doi.org/10.1016/j.intimp.2023.109822
Vancouver
Cui L, Guo J, Wang Z, Zhang J, Li W, Dong J, et al. Meloxicam inhibited oxidative stress and inflammatory response of LPS-stimulated bovine endometrial epithelial cells through Nrf2 and NF-κB pathways. International Immunopharmacology. 2023;116:109822. doi:10.1016/j.intimp.2023.109822
BibTeX
@article{Cui2023,
author = {Cui, Luying and Guo, Jing and Wang, Zhihao and Zhang, Jiaqi and Li, Wenjie and Dong, Junsheng and Liu, Kangjun and Guo, Long and Li, Jun and Wang, Heng and Li, Jianji},
title = {Meloxicam inhibited oxidative stress and inflammatory response of LPS-stimulated bovine endometrial epithelial cells through Nrf2 and NF-κB pathways},
journal = {International Immunopharmacology},
year = {2023},
volume = {116},
pages = {109822},
doi = {10.1016/j.intimp.2023.109822}
}
EUVIMED